Zurcher Kantonalbank (Zurich Cantonalbank) Bellus Health Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023
SELL
$7.14 - $8.53 $21,384 - $25,547
-2,995 Reduced 18.82%
12,920 $93,000
Q4 2022

Feb 01, 2023
BUY
$8.22 - $10.76 $11,894 - $15,569
1,447 Added 10.0%
15,915 $130,000
Q2 2022

Aug 09, 2022
BUY
$6.46 - $10.02 $68,243 - $105,851
10,564 Added 270.59%
14,468 $133,000
Q1 2022

Apr 21, 2022
BUY
$5.56 - $7.99 $21,706 - $31,192
3,904 New
3,904 $27,000
Q4 2020

Jan 28, 2021
SELL
$2.27 - $3.3 $13,254 - $19,268
-5,839 Closed
0 $0
Q2 2020

Jul 28, 2020
BUY
$8.88 - $11.15 $51,850 - $65,104
5,839 New
5,839 $61,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email